Mutual of America Capital Management LLC lowered its stake in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 2.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 331,535 shares of the company's stock after selling 9,468 shares during the period. Mutual of America Capital Management LLC owned 0.21% of American Healthcare REIT worth $12,181,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Wolff Wiese Magana LLC bought a new position in shares of American Healthcare REIT during the first quarter valued at $25,000. Physician Wealth Advisors Inc. bought a new position in shares of American Healthcare REIT during the second quarter valued at $34,000. Avalon Trust Co bought a new position in shares of American Healthcare REIT during the first quarter valued at $36,000. Continuum Advisory LLC bought a new position in shares of American Healthcare REIT during the first quarter valued at $37,000. Finally, Tsfg LLC bought a new position in shares of American Healthcare REIT during the first quarter valued at $41,000. Institutional investors and hedge funds own 16.68% of the company's stock.
Insider Activity
In other news, EVP Mark E. Foster sold 3,850 shares of the company's stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total value of $161,276.50. Following the completion of the sale, the executive vice president owned 59,100 shares of the company's stock, valued at approximately $2,475,699. This represents a 6.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.00% of the company's stock.
American Healthcare REIT Stock Performance
American Healthcare REIT stock opened at $43.34 on Monday. The firm's 50 day simple moving average is $41.92 and its 200 day simple moving average is $37.18. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $7.31 billion, a PE ratio of -196.99, a price-to-earnings-growth ratio of 2.23 and a beta of 0.98. American Healthcare REIT, Inc. has a 1-year low of $24.21 and a 1-year high of $43.52.
American Healthcare REIT (NYSE:AHR - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.02. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. The business had revenue of $542.50 million during the quarter, compared to analysts' expectations of $539.49 million. During the same quarter in the previous year, the company earned $0.33 EPS. The business's quarterly revenue was up 7.5% compared to the same quarter last year. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. As a group, analysts expect that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current fiscal year.
American Healthcare REIT Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 17th. Stockholders of record on Tuesday, September 30th were paid a $0.25 dividend. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.3%. American Healthcare REIT's dividend payout ratio is -454.55%.
Wall Street Analyst Weigh In
AHR has been the subject of several analyst reports. Truist Financial raised their price target on shares of American Healthcare REIT from $44.00 to $46.00 and gave the company a "buy" rating in a research note on Tuesday, August 26th. Baird R W raised shares of American Healthcare REIT to a "strong-buy" rating in a research note on Thursday, July 17th. KeyCorp raised their price target on shares of American Healthcare REIT from $40.00 to $43.00 and gave the company an "overweight" rating in a research note on Tuesday, October 14th. Morgan Stanley reaffirmed an "overweight" rating on shares of American Healthcare REIT in a research note on Wednesday, September 3rd. Finally, UBS Group initiated coverage on shares of American Healthcare REIT in a research note on Friday, September 19th. They set a "buy" rating and a $51.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat, American Healthcare REIT currently has a consensus rating of "Buy" and a consensus price target of $45.00.
Read Our Latest Research Report on American Healthcare REIT
American Healthcare REIT Profile
(
Free Report)
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.